WG Partners

WG Partners is a private, partner-owned corporate advisory firm focused exclusively on the life sciences sector, including biotech, pharma, medtech, and digital health. It differentiates itself through a conflict-free model, acting solely for corporate clients and leveraging its team's extensive City experience and international investor relationships to execute M&A and financing transactions. With a strong track record of cross-border deals and a stable team boasting over 250 years of combined relevant experience, the firm is a established niche player in European life sciences finance with a growing footprint in Australia.

The firm's platform is its intellectual capital, sector expertise, and global network of institutional investor and life sciences industry relationships, used to provide corporate finance advisory, M&A, and capital raising services.

WG Partners competes with the healthcare teams of large global investment banks (e.g., Morgan Stanley, Goldman Sachs) and larger European boutiques, as well as other specialized life sciences advisory firms. Its key differentiators are its exclusive focus on corporate clients (conflict-free model), deep sector specialization, and the partners' extensive hands-on experience.